Mechanistic basis of the role of Cbx3 in negatively regulating osteoclast differentiation through epigenetic modification

Cbx3通过表观遗传修饰负调节破骨细胞分化作用的机制基础

基本信息

  • 批准号:
    10463857
  • 负责人:
  • 金额:
    $ 49.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-06 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

The long term goal of this study is to develop safer and effective therapeutic approach for bone loss caused by excessive osteoclast (OC) differentiation implicated in many metabolic bone diseases. The immediate goal of this application is to understand how OC differentiation is regulated through negative signaling mediated by transcription factors and epigenetic regulators, which may serve as novel therapeutic targets for bone diseases such as osteoporosis. Current therapies for osteolytic diseases are hindered by lack of understanding of the mechanisms underlying the negative regulation of OC function to prevent bone loss. Moreover, the mechanism(s) underlying how transcriptional factors and epigenetic factors co-regulate, especially negatively co-regulate, OC differentiation and function remain unclear. We have identified Cbx3/HP1γ. Our subsequent immunoprecipitation analysis confirmed that C/EBPα interacts with Cbx3/HP1γ in OCs. Notably, our preliminary data showed that Cbx3/HP1γ overexpression inhibited OC differentiation and activity, while Cbx3/HP1γ silencing enhanced OC lineage commitment and formation. Consistently, Cbx3/HP1γ-deficient mice were found to exhibit osteoporosis-like phenotype due to enhanced OC formation and activity. Interestingly, through ChIP analysis, we found several binding sites of Cbx3/HP1γ on the promoters of C/EBPα regulated OC genes, NFATC1 and C-FOS. Our RNA-seq analysis also revealed that Cbx3 deficiency in monocytes led to increased OC gene expression. Collectively, the preliminary data indicated that Cbx3 can restrict C/EBPα-mediated OC differentiation and activity. Based on our preliminary studies, we hypothesize that Cbx3 negatively regulates osteoclast differentiation through interacting with C/EBPα and epigenetic factors as a result of epigenetic modification and preventing osteoclast gene expression in bone homeostasis. We will test the hypothesis through three specific aims. In Aim 1, we examine the function of Cbx3 in OC differentiation, skeletal development and bone homeostasis under physiological and pathological conditions through characterization of the phenotypes and pathomechanism in two Cbx3 CKO mouse models through loss-of-function studies. In Aim 2, we determine the role of Cbx3 in OC differentiation, skeletal development and bone homeostasis under physiological and pathological conditions by characterizing the phenotypes and pathomechanism in Cbx3 conditional transgenic overexpression mice through gain-of-function approach. We define the molecular mechanism underlying how Cbx3 negatively regulates OC differentiation through interacting with C/EBPα and controlling epigenetic modification in Aim 3. The study will elucidate the mechanism(s) through which Cbx3 cooperates with transcriptional factors and other epigenetic factors to negatively regulate OC differentiation and activity. Insights gained from this study will not only address the basic scientific question about epigenetic regulation of gene expression in OC biology, but also will provide the foundation for the ultimate goal of facilitating the design of safer and novel therapeutic approach for osteolytic diseases (e.g. osteoporosis).
本研究的长期目标是开发更安全,有效的治疗方法, 破骨细胞(OC)过度分化与许多代谢性骨疾病有关。这一近期目标 本申请旨在了解OC分化是如何通过负信号调节的, 转录因子和表观遗传调节因子,可能成为骨疾病的新治疗靶点 如骨质疏松症。目前用于溶骨性疾病的疗法由于缺乏对溶骨性疾病的分子机制的了解而受到阻碍。 负调节OC功能以防止骨丢失的潜在机制。而且 转录因子和表观遗传因子如何共同调节的潜在机制,特别是负调节 但是,OC的分化和功能尚不清楚。我们鉴定了Cbx 3/HP 1 γ。我们随后 免疫沉淀分析证实C/EBPα与Cbx 3/HP 1 γ在OC中相互作用。值得注意的是,我们的初步 Cbx 3/HP 1 γ过表达抑制OC的分化和活性,而Cbx 3/HP 1 γ沉默抑制OC的分化和活性。 增强OC谱系承诺和形成。同样,发现Cbx 3/HP 1 γ缺陷小鼠表现出 由于OC的形成和活性增强而导致的类神经纤维瘤表型。有趣的是,通过ChIP分析,我们 在C/EBPα调控的OC基因、NFATC 1和NFATC 2的启动子上发现了Cbx 3/HP 1 γ的几个结合位点, C-FOS我们的RNA-seq分析还显示,单核细胞中Cbx 3缺陷导致OC基因表达增加, 表情总的来说,初步数据表明,Cbx 3可以限制C/EBPα介导的OC 分化和活动。基于我们的初步研究,我们假设Cbx 3负调节 破骨细胞的分化是通过与C/EBPα和表观遗传因子相互作用, 修饰和阻止破骨细胞基因表达的骨稳态。我们将检验这个假设 通过三个具体目标。在目的1中,我们研究了Cbx 3在OC分化、骨骼肌分化和成纤维细胞分化中的作用。 发育和骨稳态的生理和病理条件下,通过表征 通过功能丧失研究,在两种Cbx 3 CKO小鼠模型中观察表型和病理机制。在Aim中 2.我们确定了Cbx 3在OC分化,骨骼发育和骨稳态中的作用, 通过表征Cbx 3中的表型和病理机制, 条件性转基因过表达小鼠通过获得功能的方法。我们定义分子 Cbx 3通过与C/EBPα相互作用负调控OC分化的机制, 控制目标3中的表观遗传修饰。该研究将阐明Cbx 3 与转录因子和其他表观遗传因子合作,负调控OC分化, 活动从这项研究中获得的见解不仅将解决关于表观遗传的基本科学问题, OC生物学中基因表达的调控,也将为最终目标的实现提供基础。 促进设计更安全和新颖的溶骨性疾病(例如骨质疏松症)的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YI-PING LI其他文献

YI-PING LI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YI-PING LI', 18)}}的其他基金

G13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis
G13 信号传导可减轻年龄相关性牙周炎小鼠模型中的牙周炎症和牙槽骨丢失
  • 批准号:
    10404267
  • 财政年份:
    2021
  • 资助金额:
    $ 49.59万
  • 项目类别:
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling
通过靶向细胞内源性负信号传导抑制牙周病中的炎症和骨侵蚀
  • 批准号:
    10405318
  • 财政年份:
    2021
  • 资助金额:
    $ 49.59万
  • 项目类别:
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
化疗增强癌症恶病质肌肉萎缩的机制
  • 批准号:
    10362568
  • 财政年份:
    2021
  • 资助金额:
    $ 49.59万
  • 项目类别:
G13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis
G13 信号传导可减轻年龄相关性牙周炎小鼠模型中的牙周炎症和牙槽骨丢失
  • 批准号:
    10444932
  • 财政年份:
    2021
  • 资助金额:
    $ 49.59万
  • 项目类别:
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling
通过靶向细胞内源性负信号传导抑制牙周病中的炎症和骨侵蚀
  • 批准号:
    10327686
  • 财政年份:
    2021
  • 资助金额:
    $ 49.59万
  • 项目类别:
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling
通过靶向细胞内源性负信号传导抑制牙周病中的炎症和骨侵蚀
  • 批准号:
    10559645
  • 财政年份:
    2021
  • 资助金额:
    $ 49.59万
  • 项目类别:
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
化疗增强癌症恶病质肌肉萎缩的机制
  • 批准号:
    10550259
  • 财政年份:
    2021
  • 资助金额:
    $ 49.59万
  • 项目类别:
Targeting circulating HSP70 and HSP90 for the treatment of cancer cachexia
靶向循环 HSP70 和 HSP90 治疗癌症恶病质
  • 批准号:
    10212970
  • 财政年份:
    2020
  • 资助金额:
    $ 49.59万
  • 项目类别:
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis
表征树突状细胞和巨噬细胞中的负信号传导以减轻类风湿性关节炎的炎症和骨质破坏
  • 批准号:
    10616608
  • 财政年份:
    2020
  • 资助金额:
    $ 49.59万
  • 项目类别:
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis
表征树突状细胞和巨噬细胞中的负信号传导以减轻类风湿性关节炎的炎症和骨质破坏
  • 批准号:
    10405848
  • 财政年份:
    2020
  • 资助金额:
    $ 49.59万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
  • 批准号:
    DP240103141
  • 财政年份:
    2024
  • 资助金额:
    $ 49.59万
  • 项目类别:
    Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
  • 批准号:
    MR/X00029X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
    Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
  • 批准号:
    2312378
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
    Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
  • 批准号:
    23K06408
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
  • 批准号:
    10680969
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
  • 批准号:
    10744556
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
  • 批准号:
    23K06597
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
  • 批准号:
    23K05034
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
  • 批准号:
    2838427
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
    Studentship
RNA-binding proteins in bacterial virulence and host-pathogen interactions
RNA结合蛋白在细菌毒力和宿主-病原体相互作用中的作用
  • 批准号:
    10659346
  • 财政年份:
    2023
  • 资助金额:
    $ 49.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了